206 related articles for article (PubMed ID: 14600028)
1. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis.
Budisavljevic MN; Hodge L; Barber K; Fulmer JR; Durazo-Arvizu RA; Self SE; Kuhlmann M; Raymond JR; Greene EL
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1138-48. PubMed ID: 14600028
[TBL] [Abstract][Full Text] [Related]
2. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
Bessho K; Mizuno S; Matsumoto K; Nakamura T
Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
4. Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of the anti-oxidant alpha-lipoic acid.
Singh LP; Cheng DW; Kowluru R; Levi E; Jiang Y
Cell Biochem Funct; 2007; 25(5):537-50. PubMed ID: 16892452
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.
Polihronis M; Murphy BF; Pearse MJ; Power DA
Exp Nephrol; 1996; 4(5):271-8. PubMed ID: 8931982
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
Wu SH; Wu XH; Liao PY; Dong L
Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
[TBL] [Abstract][Full Text] [Related]
9. [Expression of FGF2, FGF receptor-1 and alpha-smooth muscle actin in experimental mesangial proliferative nephritis].
Jyo Y
Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):545-54. PubMed ID: 9014473
[TBL] [Abstract][Full Text] [Related]
10. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.
Floege J; Eng E; Lindner V; Alpers CE; Young BA; Reidy MA; Johnson RJ
J Clin Invest; 1992 Dec; 90(6):2362-9. PubMed ID: 1361494
[TBL] [Abstract][Full Text] [Related]
11. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
12. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.
Chadban SJ; Tesch GH; Foti R; Atkins RC; Nikolic-Paterson DJ
Lab Invest; 1997 May; 76(5):619-27. PubMed ID: 9166281
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
16. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding EGF-like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis.
Takemura T; Murata Y; Hino S; Okada M; Yanagida H; Ikeda M; Yoshioka K
J Pathol; 1999 Nov; 189(3):431-8. PubMed ID: 10547607
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis.
Matsumoto M; Fujimoto S; Iwatsubo S; Sato Y; Hara S; Kitamura K; Eto T
Clin Exp Nephrol; 2004 Dec; 8(4):316-21. PubMed ID: 15619030
[TBL] [Abstract][Full Text] [Related]
20. Activation of mesangial cell MAPK in response to homocysteine.
Ingram AJ; Krepinsky JC; James L; Austin RC; Tang D; Salapatek AM; Thai K; Scholey JW
Kidney Int; 2004 Aug; 66(2):733-45. PubMed ID: 15253728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
